Jonas Hugosson

1993–2025 年に発表

93
論文数
18,116
被引用数
63
h 指数
92
i10 指数

被引用数

Jonas Hugosson の年別被引用数1976 年: 被引用 2 件1995 年: 被引用 4 件1996 年: 被引用 1 件1997 年: 被引用 9 件1998 年: 被引用 5 件1999 年: 被引用 12 件2000 年: 被引用 15 件2001 年: 被引用 14 件2002 年: 被引用 19 件2003 年: 被引用 35 件2004 年: 被引用 23 件2005 年: 被引用 23 件2006 年: 被引用 25 件2007 年: 被引用 30 件2008 年: 被引用 44 件2009 年: 被引用 90 件2010 年: 被引用 141 件2011 年: 被引用 170 件2012 年: 被引用 179 件2013 年: 被引用 188 件2014 年: 被引用 192 件2015 年: 被引用 188 件2016 年: 被引用 142 件2017 年: 被引用 129 件2018 年: 被引用 161 件2019 年: 被引用 347 件2020 年: 被引用 361 件2021 年: 被引用 332 件2022 年: 被引用 287 件2023 年: 被引用 267 件2024 年: 被引用 465 件2025 年: 被引用 170 件2026 年: 被引用 4 件1977〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,206 件、この内訳の 23.2%イギリス: 引用元論文 454 件、この内訳の 8.7%オランダ: 引用元論文 346 件、この内訳の 6.6%ドイツ: 引用元論文 292 件、この内訳の 5.6%スウェーデン: 引用元論文 281 件、この内訳の 5.4%イタリア: 引用元論文 279 件、この内訳の 5.4%カナダ: 引用元論文 265 件、この内訳の 5.1%フランス: 引用元論文 236 件、この内訳の 4.5%中国: 引用元論文 233 件、この内訳の 4.5%オーストラリア: 引用元論文 152 件、この内訳の 2.9%スペイン: 引用元論文 125 件、この内訳の 2.4%フィンランド: 引用元論文 116 件、この内訳の 2.2%
0%23.2%その他 23.5%

分野

  • Medicine83.2%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Computer Science1.7%
  • Health Professions1.2%
  • Engineering0.8%
  • Chemistry0.7%
  • その他2.6%

トピック

  • Prostate Cancer Diagnosis and Treatment23.1%
  • Prostate Cancer Treatment and Research19.2%
  • Global Cancer Incidence and Screening4.3%
  • Urologic and reproductive health conditions2.3%
  • Urinary Bladder and Prostate Research2.1%
  • AI in cancer detection1.9%
  • その他47.1%

共著者

全論文

検索で開く
  1. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anssi Auvinen - European Urology 2019 被引用: 698

  2. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 359

  3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2014 被引用: 1,565

  4. Screening and Prostate-Cancer Mortality in a Randomized European Study

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 被引用: 4,014

  5. Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

    著者: , , , , , , , , , , - The Journal of Urology 2022 被引用: 90

  6. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

    著者: , , , , , , , , , , , - European Urology 2015 被引用: 491

  7. Prostate-Cancer Mortality at 11 Years of Follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,241

  8. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2017 被引用: 247

  9. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

    著者: , , , , , , , , , - The Lancet Oncology 2010 被引用: 936

  10. Results after Four Years of Screening for Prostate Cancer with PSA and MRI

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 107

  11. Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

    著者: , , , , , , , , , , , , - European Urology 2023 被引用: 62

  12. Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

    著者: , , , , - European Urology 2014 被引用: 166

  13. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Valdagni, Antoinette S. Perry, Jonas Hugosson, J. Rubio‐Briones, Anders Bjartell, Lukas Hefermehl, Lee Lui Shiong, Mark Frydenberg, Yoshiyuki Kakehi, Byung Ha Chung, Theodorus van der Kwast, Henk Obbink, Wim van der Linden, Tim Hulsen, Cees de Jonge, Mike Kattan, Xinge Ji, Kenneth Muir, Artitaya Lophatananon, Michael Fahey, Ewout W. Steyerberg, Daan Nieboer, Liying Zhang, Ewout W. Steyerberg, Daan Nieboer, A. Santa Olalla, Kerri Beckmann, Brian T. Denton, Andrew Hayen, Paul C. Boutros, Wei Guo, Nicole Benfante, Janet E. Cowan, Dattatraya Patil, Emily Tolosa, Tae-Kyung Kim, Alexandre Mamedov, Vincent La Pointe, Trafford Crump, Jenna Kimberly-Duffell, Aida Santaolalla, Daan Nieboer, Jonathan Olivier, T. Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Anders Bjartell, Masoom A. Haider, Kees van Bochove, Ballentine Carter, Sam Gledhill, Mark Buzza, Chris H. Bangma, Monique J. Roobol, Sophie Bruinsma, Jozien Helleman - European Urology 2018 被引用: 93

  14. Quality-of-Life Effects of Prostate-Specific Antigen Screening

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 425

  15. Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

    著者: , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 被引用: 161

  16. The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

    著者: , , , , , , , - Scandinavian Journal of Urology 2021 被引用: 57

  17. Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

    著者: , , , , , , - European Urology 2022 被引用: 36

  18. Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery

    著者: , , , , , , , , , , , , , , - European Urology 2014 被引用: 162

  19. Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality

    著者: , , , , , , , , , - Scandinavian Journal of Urology 2017 被引用: 107

  20. Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years

    著者: , , , , , , - JAMA Network Open 2020 被引用: 52

  21. Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

    著者: , , , , , , , , - European Urology 2012 被引用: 267

  22. The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

    著者: , , , , - European Urology 2022 被引用: 73

  23. Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

    著者: , , , , , , , - BMJ Oncology 2023 被引用: 30

  24. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial

    著者: , , , , , - European Urology 2016 被引用: 163